Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 54 Lymphoma 40 Lymphoma, Large B-Cell, Diffuse 28 Lymphoma, Non-Hodgkin 21 Hodgkin Disease 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Osteosarcoma 17 Testicular Neoplasms 15 Burkitt Lymphoma 15 Leukemia 14 Lymphoma, Large-Cell, Immunoblastic 13 Lymphoma, Follicular 13 Ovarian Neoplasms 12 Lymphoma, Mantle-Cell 12 Neuroectodermal Tumors, Primitive, Peripheral 11 Testicular Germ Cell Tumor 10 Liposarcoma 10 Histiocytoma, Malignant Fibrous 10 Hemangiosarcoma 10 Fibrosarcoma 10 Sarcoma, Synovial 9 Rhabdomyosarcoma 9 Neurofibrosarcoma 9 Lymphoma, Large-Cell, Anaplastic 9 Leiomyosarcoma 9 Teratoma 8 Recurrence 8 Neuroblastoma 8 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Lymphocytic, Chronic, B-Cell 8

Interventions

midostaurin 2 vandetanib 1 selinexor 1 pegfilgrastim 1 Topotecan 1 Rituximab 1 Prednisone 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Bexarotene 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Aggression × Ifosfamide × Clear all

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡